汇添富恒生生物科技ETF(QDII)(513280)财务指标
| |
2024-12-31 |
2024-06-30 |
2023-12-31 |
2023-06-30 |
| 本期已实现收益 |
-10,542,868.64 |
-6,624,112.28 |
-2,313,836.51 |
1,932,517.14 |
| 本期利润 |
-16,443,521.37 |
-40,280,689.12 |
-13,738,761.93 |
-13,237,190.80 |
| 加权平均基金份额本期利润 |
-0.06 |
-0.17 |
-0.13 |
-0.15 |
| 本期加权平均净值利润率(%) |
-9.44 |
-26.88 |
-14.73 |
-16.22 |
| 本期基金份额净值增长率(%) |
-13.09 |
-27.23 |
-22.98 |
-20.87 |
| 期末可供分配利润 |
-99,691,504.78 |
-128,213,616.86 |
-35,466,846.12 |
-19,373,677.35 |
| 期末可供分配基金份额利润 |
-0.32 |
-0.43 |
-0.22 |
-0.20 |
| 期末基金资产净值 |
207,422,952.22 |
166,900,840.14 |
123,647,610.88 |
76,740,779.65 |
| 期末基金份额净值 |
0.68 |
0.57 |
0.78 |
0.80 |
| 基金份额累计净值增长率(%) |
-32.46 |
-43.45 |
-22.29 |
-20.16 |
微信公众号
证券之星APP
基本资料
